Alpha Tau Medical (DRTS) Competitors

Alpha Tau Medical (NASDAQ:DRTS) and AxoGen (NASDAQ:AXGN) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, community ranking, profitability, valuation and dividends.

Do analysts recommend DRTS or AXGN?

Alpha Tau Medical presently has a consensus target price of $8.00, suggesting a potential upside of 206.51%. AxoGen has a consensus target price of $22.60, suggesting a potential upside of 34.13%. Given Alpha Tau Medical's higher possible upside, equities research analysts clearly believe Alpha Tau Medical is more favorable than AxoGen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Tau Medical	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
AxoGen	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more risk and volatility, DRTS or AXGN?

Alpha Tau Medical has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500. Comparatively, AxoGen has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.

Which has stronger earnings & valuation, DRTS or AXGN?

AxoGen has higher revenue and earnings than Alpha Tau Medical. AxoGen is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Tau Medical	N/A	N/A	-$29.16M	-$0.45	-5.80
AxoGen	$187.34M	3.99	-$21.72M	-$0.22	-76.59

Is DRTS or AXGN more profitable?

Alpha Tau Medical has a net margin of 0.00% compared to AxoGen's net margin of -7.91%. AxoGen's return on equity of -14.91% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Tau Medical	N/A	-38.62%	-29.89%
AxoGen	-7.91%	-14.91%	-7.49%

Does the MarketBeat Community prefer DRTS or AXGN?

AxoGen received 436 more outperform votes than Alpha Tau Medical when rated by MarketBeat users. Likewise, 72.89% of users gave AxoGen an outperform vote while only 72.41% of users gave Alpha Tau Medical an outperform vote.

Company	Underperform	Outperform
Alpha Tau Medical	Outperform Votes 21 72.41%	Underperform Votes 8 27.59%
AxoGen	Outperform Votes 457 72.89%	Underperform Votes 170 27.11%

Does the media prefer DRTS or AXGN?

In the previous week, AxoGen had 1 more articles in the media than Alpha Tau Medical. MarketBeat recorded 7 mentions for AxoGen and 6 mentions for Alpha Tau Medical. AxoGen's average media sentiment score of 1.33 beat Alpha Tau Medical's score of 0.50 indicating that AxoGen is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Tau Medical	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
AxoGen	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders & institutionals believe in DRTS or AXGN?

2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 80.3% of AxoGen shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by insiders. Comparatively, 7.0% of AxoGen shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

AxoGen beats Alpha Tau Medical on 12 of the 16 factors compared between the two stocks.